高级检索
当前位置: 首页 > 详情页

Evaluation of seven recombinant VCA-IgA ELISA kits for the diagnosis of nasopharyngeal carcinoma in China: a case-control trial

文献详情

资源类型:
机构: [1]Sun Yat Sen Univ, Dept Canc Prevent, State Key Lab Oncol Southern China, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [2]Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China; [3]Sun Yat Sen Univ, Dept Nasopharyngeal Carcinoma, State Key Lab Oncol Southern China, Canc Ctr, Guangzhou, Peoples R China; [4]Guangzhou Women & Childrens Med Ctr, Div Birth Cohort Study, Guangzhou, Guangdong, Peoples R China; [5]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Clin Res Ctr, Guangzhou, Guangdong, Peoples R China
出处:
ISSN:

关键词: Diagnostic effect Epstein-Barr virus Nasopharyngeal carcinoma Screening VCA-IgA

摘要:
Objective Seven recombinant viral capsid antigen-IgA (VCA-IgA) ELISA kits are widely used in China, but their diagnostic effects have not been evaluated. In this study, we evaluated whether the diagnostic effects of these kits are similar to those of the standard kit (EUROIMMUN, Lubeck, Germany). Methods A diagnostic case-control trial was conducted with 200 cases of nasopharyngeal carcinoma (NPC) and 200 controls from NPC-endemic areas in southern China. The areas under the curve (AUCs), the sensitivities and the specificities of testing kits were compared with those of the standard kit. The test-retest reliability of each kit was determined by intraclass correlation coefficient (ICC). Their diagnostic accuracy in combination with Epstein-Barr virus nuclear antigen 1-IgA (EBNA1-IgA) was also evaluated in logistic models. Results Three testing kits-BB, HA and KSB-showed diagnostic accuracy equal to that of the standard kit, with good performance in the AUCs (0.926-0.945), and no significant differences in sensitivity were found between early-stage and advanced-stage NPCs. ICCs exceeded 0.8. Three logistic regression models were built, and the AUCs of these models (0.961-0.977) were better than those of the individual VCA-IgA kits. All new models had diagnostic accuracy equal to that of the standard kit. New cut-off values of these three kits and their corresponding combinations for researchers to replicate and use in NPC early detection and screening in the future were provided. Conclusions Three recombinant VCA-IgA kits-BB, HA and KSB-had diagnostic effects equal to those of the standard kit, and, in combination with EBNA1-IgA in logistic regression models, can be used in future screening for NPC.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 3 区 医学
小类 | 3 区 医学:内科
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 医学:内科
第一作者:
第一作者机构: [1]Sun Yat Sen Univ, Dept Canc Prevent, State Key Lab Oncol Southern China, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [2]Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China;
通讯作者:
通讯机构: [1]Sun Yat Sen Univ, Dept Canc Prevent, State Key Lab Oncol Southern China, Canc Ctr, Guangzhou, Guangdong, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号